Печень в норме: программа очищения и восстановления печени при явных и скрытых заболеваниях - Кристин Киркпатрик

Pepino, M. Y., C. D. Tiemann, B. W. Patterson, B. M. Wice, and S. Klein. 2013. «Sucralose Affects Glycemic and Hormonal Responses to an Oral GlucoseLoad.» Diabetes Care 36 (9) (April): 2530–35.

Piguet, A. C., U. Saran, C. Simillion, I. Keller, L. Terracciano, H. L. Reeves, and J.F. Dufour. 2015. «Regular Exercise Decreases Liver Tumors Development inHepatocyte-Specific PTEN-Deficient Mice Independently of Steatosis.» Journal of Hepatology 62 (6) (June): 1296–1303.

Pinto C. G., M. Marega, J. A. Carvalho, F. G. Carmona, C. E. Lopes, F. L. Ceschini,D. S. Bocalini, and A. J. Figueira Jr. 2015. «Physical Activity as a ProtectiveFactor for Development of Non-alcoholic Fatty Liver in Men.» Einstein 13 (1)(January–March): 34–40.

Polyzos, S. A., J. Kountouras, and M. A. Tsoukas. 2015. «Circulating Homocysteine in Nonalcoholic Fatty Liver Disease.» European Journal of Internal Medicine 26 (2) March 1): 152–53.

Privitera, G. J., and H. E. Creary. 2012. «Proximity and Visibility of Fruits andVegetables Influence Intake in a Kitchen Setting Among College Students.»Environment and Behavior (April 17). Published online before print. http://eab.sagepub.com/content/45/7/876.

Purcell, K., P. Sumithran, L. A. Prendergast, C. J. Bouniu, E. Delbridge, andJ. Proietto. 2014. «The Effect of Rate of Weight Loss on Long-Term WeightManagement: A Randomized Controlled Trial.» Lancet: Diabetes & Endocrinology. Published online (October 15). http://dx.doi.org/10.1016/S2213-8587(14)70200-1.

Rocha, R., H. P. Cotrim, A. C. Siqueira, and S. Floriano. 2007. «Non AlcoholicFatty Liver Disease: Treatment with Soluble Fibres.» Arquivos de Gastroenterologia 44 (4) (October–December): 350–52.

Rodríguez-Roisin, R., and M. J. Krowka. 2008. «Hepatopulmonary Syndrome–A Liver-Induced Lung Vascular Disorder.» New England Journal of Medicine 358 (May 29): 2378–87.

Rogers, M. A., and D. M. Aronoff. 2016. «The Influence of Non-steroidal AntiInflammatory Drugs on the Gut Microbiome.» Clinical Microbiology and Infection 22 (2) (February): 178.

Russ, T. C., M. Kivimäki, J. R. Morling, J. M. Starr, E. Stamatakis, and G. D.Batty. 2015. «Association Between Psychological Distress and Liver DiseaseMortality: A Meta-analysis of Individual Study Participants.» Gastroenterology 148: 958–66.

Sabry, A. A., M. A. Sobh, W. L. Irving, A. Grabowska, B. E. Wagner, S. Fox, G.Kudesia, and A. M. El Nahas. 2002. «A Comprehensive Study of the Association Between Hepatitis C Virus and Glomerulopathy.» Nephrology DialysisTransplantation 17 (2): 239–45.

Saich, R., and R. Chapman. 2008 «Primary Sclerosing Cholangitis, Autoimmune Hepatitis and Overlap Syndromes in Inflammatory Bowel Disease.» WorldJournal of Gastroenterology 14 (3) (January 21): 331–37.

Sanyal, A. J., N. Chalasani, K. V. Kowdley, A. McCullough, A. M. Diehl, N. M.Bass, B. A. Neuschwander-Tetri, J. E. Lavine, J. Tonascia, A. Unalp, M. VanNatta, J. Clark, E. M. Brunt, D. E. Kleiner, J. H. Hoofnagle, and P. R. Robuck. 2010. «Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.» New England Journal of Medicine 362 (May 6): 1675–85

Schiff, E. R., W. C. Maddrey, and M. F. Sorrell. 2011. Schiff’s Diseases of the Liver, 11th ed. Hoboken, NJ: Wiley-Blackwell.

Schwimmer, J. B., C. Behling, R. Newbury, R. Deutsch, C. Nievergelt, N. J.Schork, and J. E. Lavine. 2005. «Histopathology of Pediatric Nonalcoholic Fatty Liver Disease.» Hepatology 42 (3) (September): 641–49.

Schwimmer, J. B., R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, C. Behling.2006. «Prevalence of Fatty Liver in Children and Adolescents.» Pediatrics 118 (4) (October): 1388–93.

Schwimmer, J. B., N. McGreal, R. Deutsch, M. J. Finegold, and J. E. Lavine. 2005. «Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in ObeseAdolescents.» Pediatrics 115 (5) (May): e561–e565.

Schwimmer, J. B., M. S. Middleton, C. Behling, K. P. Newton, H. I. Awai, M. N.Paiz, J. Lam, J. C. Hooker, G. Hamilton, J. Fontanesi, and C. B. Sirlin. 2015. «Magnetic Resonance Imaging and Liver Histology as Biomarkers of Hepatic Steatosis in Children with Nonalcoholic Fatty Liver Disease.» Hepatology 61 (6) (June): 1887–95.

Shamsoddini, A., V. Sobhani, M. E. Chamar Chehreh, S. M. Alavian, and A.Zaree. 2015. «Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men with Nonalcoholic Fatty Liver Disease.» Hepatitis Monthly 15 (10) (October 10): e31434.

Shapiro, A., W. Mu, C. Roncal, K.-Y. Cheng, R. J. Johnson, and P. J. Scarpace.2008. «Fructose-Induced Leptin Resistance Exacerbates Weight Gain in Response to Subsequent High-Fat Feeding.» American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 295 (5) (November 1): R1370–R1375.

Sharifi, N., R. Amani, E. Jahiani, and B. Cheraghian. 2014. «Does Vitamin DImprove Liver Enzymes, Oxidative Stress, and Inflammatory Biomarkersin Adults with Non-alcoholic Fatty Liver Disease? A Randomized Clinical Trial.» Endocrine 47 (1) (September): 70–80.

Sharma, K. K., U. K. T. Prasada, and P. Kumar. 2014. “«A Study on the Effect of Yoga Therapy on Liver Functions.» European Scientific Journal 10 (6) (February): 246–51.

Sharma, V., G. Shashank, and S. Aggarwal. 2013. «Probiotics and Liver Disease.» Permanente Journal 17 (4) (Fall): 62–67.

Shimazu, T., Y. Tsubono, S. Kuriyama, K. Ohmori, Y. Koizumi, Y. Nishino, D.Shibuya, and I. Tsuji. 2005. «Coffee Consumption and the Risk of PrimaryLiver Cancer: Pooled Analysis of Two Prospective Studies in Japan.» International Journal of Cancer 116 (1) (August 10): 150–54.

Slack, A., A. Yeoman, and J. Wendon. 2010. «Renal Dysfunction in Chronic Liver Disease.» Critical Care 14 (2) (March 9): 214.

Sreenivasa Baba, C., G. Alexander, B. Kalyani, R. Pandey, S. Rastogi, A. Pandey, and G. Choudhuri. 2006. «Effect of Exercise and Dietary Modificationon Serum Aminotransferase Levels in Patients with Nonalcoholic Steatohepatitis.» Journal of Gastroenterology and Hepatology 21 (1 Pt 1) (January): 191–98.

Targher, G., C. P. Day, and E. Bonora. 2010. «Risk of Cardiovascular Diseasein Patients with Nonalcoholic Fatty Liver Disease.» New England Journal ofMedicine 363 (September 30): 1341–50.

Tremaroli, V., and F. Bäckhed. 2012. «Functional Interactions Between theGut Microbiota and Host Metabolism.» Nature 489 (7415) (September 13): 242–49.

Trovato, F. M., D. Catalano, G. F. Martines, P. Pace, and G. M. Trovato. 2015. «Mediterranean Diet and Non-alcoholic Fatty Liver Disease: The Need ofExtended and Comprehensive Interventions.» Clinical Nutrition 34 (1) (February): 86–88.

Valenti, L., P. Riso, A. Mazzocchi, M. Porrini, S. Fargion, and C. Agostoni, C.2013. «Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic FattyLiver Disease.» Oxidative Medicine and Cellular Longevity 2013: 145421.

Valtueña, S., N. Pellegrini, D. Ardigò, D. Del Rio, F. Numeroso, F. Scazzina, L.Monti, I. Zavaroni, and F. Brighenti. 2006. «Dietary Glycemic Index andLiver Steatosis.» American Journal